Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 06/30/03
End: 12/31/06
Due: 12/31/07
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study | NCT00525577 | AtheroGenics | user2@example.com | None | 2007-08-31 | 2008-09-30 | 2009-09-30 | - | - | 2025-07-14 |
| ARISE - Aggressive Reduction of Inflammation Stops Events | NCT00066898 | AtheroGenics | user2@example.com | None | 2003-06-30 | 2006-12-31 | 2007-12-31 | - | - | 2025-07-14 |